Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Lack of effect of donor–recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation volume 38, pages 615–620 (2006)Cite this article

Abstract

Several recently published studies have suggested that patients who undergo ABO mismatched hematopoietic stem cell transplantation may be at increased risk for relapse, graft-versus-host disease, transplant-related mortality, and/or all-cause mortality. To investigate this issue further, we analyzed potential associations between the donor–recipient ABO mismatch pattern and the above outcome measures among 240 consecutive patients who underwent allogeneic hematopoietic stem cell transplantation at our institution. Our analyses uncovered no significant associations between donor–recipient ABO mismatch pattern and overall survival, event-free survival, transplant-related mortality, incidence of acute graft-versus-host disease (GVHD), or incidence of chronic GVHD. Our data do not support recent assertions that donor–recipient ABO mismatching is a major risk factor for patients undergoing allogeneic transplant, nor do they support recent assertions that ABO matching should be an important consideration in selecting allogeneic hematopoietic stem cell donors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Warkentin PI, Yomtovian R, Hurd D, Brunning R, Swanson J, Kersey JH et al. Severe delayed hemolytic transfusion reaction complicating an ABO incompatible bone marrow transplantation. Vox Sang 1983; 45: 40–47.

    Article  CAS  Google Scholar 

  2. Hows JM, Chipping PM, Palmer S, Gordon-Smith EC . Regeneration of peripheral blood cells following ABO incompatible allogeneic bone marrow transplantation for severe aplastic anemia. Br J Haematol 1983; 53: 145–151.

    Article  CAS  Google Scholar 

  3. Marmont AM, Frassoni F, Van Lint MT, Podesta M, Lardari G, Occhini D et al. Isohemagglutinin induced pure red cell aplasia following major ABO incompatible marrow transplant for severe aplastic anemia. Resolution after plasma exchange. Exp Hematol 1983; 11 (Suppl 13): 51–53.

    Google Scholar 

  4. Gmur JP, Burger J, Schaffner A, Neftel K, Oelz O, Frey D et al. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 1990; 75: 290–295.

    CAS  Google Scholar 

  5. Klumpp TR . Immunohematologic complications of bone marrow transplantation. Bone Marrow Transplant 1991; 8: 159–170.

    CAS  Google Scholar 

  6. Klumpp TR, Block CC, Caligiuri MA, Rabinowe SN, Soiffer RJ, Ritz J et al. Immune-mediated cytopenia following bone marrow transplantation: case reports and review of the literature. Medicine 1992; 71: 73–83.

    Article  CAS  Google Scholar 

  7. Benjamin RJ, Connors JM, McGurk S, Churchill WH, Antin JH . Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia. Biol Blood Marrow Transplant 1998; 4: 151–156.

    Article  CAS  Google Scholar 

  8. Lee JH, Lee KH, Kim S, Lee JS, Kim SH, Kwon SW et al. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation. Bone Marrow Transplant 2000; 25: 179–184.

    Article  CAS  Google Scholar 

  9. Worel N, Greinix HT, Schneider B, Kurz M, Rabitsch W, Knobl P et al. Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Transfusion 2000; 40: 543–550.

    Article  CAS  Google Scholar 

  10. Bolan CD, Leitman SF, Griffith LM, Wesley RA, Procter JL, Stroncek DF et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 2001; 98: 1687–1694.

    Article  CAS  Google Scholar 

  11. Badros A, Tricot G, Toor A, Morris C, Guo C, Munshi N et al. ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning. Transfusion 2002; 42: 205–209.

    Article  Google Scholar 

  12. Xenocostas A, Yee A, Wong CJ, Sutton DM, Lipton JH, Kiss TL et al. RBC transfusion requirements after allogeneic marrow transplantation: Impact of the before-transplant Hb level on transfusion and early survival. Transfusion 2003; 43: 373–382.

    Article  Google Scholar 

  13. Bacigalupo A, Van Lint MT, Occhini D, Margiocco M, Ferrari G, Pittaluga PA et al. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation 1988; 45: 1091–1094.

    Article  CAS  Google Scholar 

  14. Benjamin RJ, McGurk S, Ralston MS, Churchill WH, Antin JH . ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion 1999; 39: 179–187.

    CAS  Google Scholar 

  15. Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D et al. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biol Blood Marrow Transplant 2001; 7: 620–630.

    Article  CAS  Google Scholar 

  16. Stussi G, Seebach L, Muntwyler J, Schanz U, Gmur J, Seebach JD . Graft-versus-host disease and survival after ABO-incompatible allogeneic bone marrow transplantation: a single-centre experience. Br J Haematol 2001; 113: 251–253.

    Article  CAS  Google Scholar 

  17. Stussi G, Muntwyler J, Passweg JR, Seebach L, Schanz U, Gmur J et al. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 30: 87–93.

    Article  CAS  Google Scholar 

  18. Kim HJ, Park CY, Park YH, Kim YJ, Kim DW, Min WS et al. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients. Bone Marrow Transplant 2003; 31: 79–86.

    Article  CAS  Google Scholar 

  19. Svennilson J, Remberger M, Ringden O . Risk factors for moderate-to-severe acute graft-vs-host disease after allogeneic stem cell transplantation in children. Ped Transplant 2003; 7: 130–136.

    Article  Google Scholar 

  20. Worel N, Kalhs P, Keil F, Prinz E, Moser K, Schulenburg A et al. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation. Transfusion 2003; 43: 1153–1161.

    Article  Google Scholar 

  21. Erker CG, Steins MB, Fischer R-J, Kienast J, Berdel WE, Sibrowski W et al. The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantation. Transfusion 2005; 45: 1382–1390.

    Article  Google Scholar 

  22. Gale RP, Feig S, Ho W, Falk P, Rippee C, Sparkes R . ABO blood group system and bone marrow transplantation. Blood 1977; 50: 185–194.

    CAS  Google Scholar 

  23. Buckner CD, Clift RA, Sanders JE, Williams B, Gray M, Storb R et al. ABO-incompatible marrow transplants. Transplantation 1978; 26: 233–238.

    Article  CAS  Google Scholar 

  24. Hershko C, Gale RP, Ho W, Fitchen J . ABH antigens and bone marrow transplantation. Br J Haematol 1980; 44: 65–73.

    Article  CAS  Google Scholar 

  25. Bensinger WI, Buckner CD, Thomas ED, Clift RA . ABO-incompatible marrow transplants. Transplantation 1982; 33: 427–429.

    Article  CAS  Google Scholar 

  26. Klumpp TR, Fairclough D, Ritz J, Soiffer R . The effect of minor ABO mismatches on the incidence of graft-versus-host disease after allogeneic bone marrow transplantation [letter]. Transplantation 1994; 57: 780–781.

    Article  CAS  Google Scholar 

  27. Mielcarek M, Leisenring W, Torok-Storb B, Storb R . Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood 2000; 96: 1150–1156.

    CAS  Google Scholar 

  28. Kollman C, Howe CWS, Anasetti C, Antin J, Davies SM, Filipovich AH et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001; 98: 2043–2051.

    Article  CAS  Google Scholar 

  29. Goldman J, Liesveld J, Nichols D, Heal J, Blumberg N . ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation. Leukemia Res 2003; 27: 489–491.

    Article  Google Scholar 

  30. Canals C, Muniz-Diaz E, Martinez C, Martino R, Moreno I, Ramos A et al. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning. Transfusion 2004; 44: 1603–1611.

    Article  Google Scholar 

  31. Bao L, Huang XJ, Liu KY, Xu LP, Chen H, Zhang YC et al. Effect of ABO-incompatibility on allogeneic hematopoietic stem cell transplantation. J Peking Univ Health Sciences 2005; 37: 126–129.

    Google Scholar 

  32. Seebach JD, Stussi G, Passweg JR, Loberiza FR, Gajewski JL, Keating A et al. ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biol Blood Marrow Transplant 2005; 11: 1006–1013.

    Article  Google Scholar 

  33. Kalaycioglu M, Copelan E, Avalos B, Klein J, Goormastic M, Bolwell B . Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide. Bone Marrow Transplant 1995; 15: 105–110.

    CAS  Google Scholar 

  34. Mehta J, Powles R, Sirohi B, Treleaven J, Kulkarni S, Saso R et al. Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia? Bone Marrow Transplant 2002; 29: 853–859.

    Article  CAS  Google Scholar 

  35. Demaria AN . Publication bias and journals as policemen. J Am Coll Cardiol 2004; 44: 1707–1708.

    Article  Google Scholar 

  36. Chalmers I, Matthews R . What are the implications of optimism bias in clinical research? Lancet 2006; 367: 449–450.

    Article  Google Scholar 

  37. Camacho LH, Bacik J, Cheung A, Spriggs DR . Presentation and subsequent publication rates of phase I oncology clinical trials. Cancer 2005; 104: 1497–1504.

    Article  Google Scholar 

  38. Dubben HH, Beck-Bornholdt HP . Systematic review of publication bias in studies on publication bias. BMJ 2005; 331: 433–434.

    Article  Google Scholar 

  39. Decullier E, Lheritier V, Chapuis F . Fate of biomedical research protocols and publication bias in France: retrospective cohort study. BMJ 2005; 331: 19–24.

    Article  Google Scholar 

  40. Chan AW, Krleza-Jeric K, Schmid I, Altman DG . Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. Canad Med Assoc J 2004; 171: 735–740.

    Article  Google Scholar 

  41. Ottaiano A, Castello G, Ascierto PA . Evidence of publication bias in clinical trials of biotherapies for solid tumors. Cancer 2005; 103: 653.

    Article  Google Scholar 

  42. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L . Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006; 295: 676–680.

    Article  CAS  Google Scholar 

  43. Parimon T, Au DH, Martin PJ, Chien JW . A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med 2006; 144: 407–414.

    Article  Google Scholar 

  44. Goodman SN, Berlin JA . The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann Intern Med 1994; 121: 200–206.

    Article  CAS  Google Scholar 

  45. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  Google Scholar 

  46. Sullivan KM . Graft-versus-host disease. In: Thomas ED, Blume KG, Forman SJ (eds). Hematopoietic Cell Transplantation, 2nd edn. Blackwell Science: Oxford, 1999, pp 515–536.

    Google Scholar 

  47. Hochberg Y . A sharper Bonferroni procedure for multiple significance testing. Biometrika 1988; 75: 800–803.

    Article  Google Scholar 

  48. Dienstag J . Liver transplantation. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper Dl et al (eds). Principles of Internal Medicine, 14th edn. McGraw-Hill: New York, 1998, pp 1721–1725.

    Google Scholar 

  49. Fry ETA . Heart and heart/lung transplantation. In: Makowka L (ed). Handbook of Transplantation Management. R.G. Landes: Austin, 1991, pp 26–37.

    Google Scholar 

  50. Klintmalm GBG, Husberg BS, Starzl TE . The organ transplanted patient – immunological concepts and immunosuppression. In: Makowka L (ed). Handbook of Transplantation Management. R.G. Landes: Austin, 1991, pp 72–108.

    Google Scholar 

Download references

Acknowledgements

We appreciate the expert data-gathering assistance of Diane Barcoski, RN, BSN.

Author information

Authors and Affiliations

  1. Fox Chase-Temple University Bone Marrow Transplant Program, Temple University School of Medicine, Philadelphia, PA, USA

    T R Klumpp, J Ulicny, R V B Emmons, M E Martin & K F Mangan

  2. Department of Pathology, Thomas Jefferson University School of Medicine, Philadelphia, PA, USA

    J H Herman

Authors
  1. T R Klumpp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J H Herman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Ulicny
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R V B Emmons
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M E Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K F Mangan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T R Klumpp.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klumpp, T., Herman, J., Ulicny, J. et al. Lack of effect of donor–recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 38, 615–620 (2006). https://doi.org/10.1038/sj.bmt.1705496

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705496

Keywords

This article is cited by

Search

Advanced search

Quick links